已选(0)清除
条数/页: 排序方式: |
| Expenditure and financial burden for the diagnosis and treatment of colorectal cancer in China: a hospital-based, multicenter, cross-sectional survey 期刊论文 CHINESE JOURNAL OF CANCER, 2017, 卷号: 36 -
![](/themes/default/image/downing1.png) 收藏  |  浏览/下载:32/0  |  提交时间:2020/10/26 CARE COSTS SURVIVORS FAMILY MORTALITY ADHERENCE PATIENT CANADA Colorectal neoplasms Direct expenditure Financial burden China |
| ABO blood group is a predictor of survival in patients with laryngeal cancer 期刊论文 CHINESE JOURNAL OF CANCER, 2016, 卷号: 35 -
![](/themes/default/image/downing1.png) 收藏  |  浏览/下载:24/0  |  提交时间:2020/10/26 GENOME-WIDE ASSOCIATION SQUAMOUS-CELL CARCINOMA PANCREATIC-CANCER NASOPHARYNGEAL CARCINOMA COHORT CONSORTIUM CHINESE PATIENTS GROUP ALLELES RISK POPULATION EXPRESSION The ABO blood group Laryngeal cancer Prognosis Survival |
| A new prognostic histopathologic classification of nasopharyngeal carcinoma 期刊论文 CHINESE JOURNAL OF CANCER, 2016, 卷号: 35 -
![](/themes/default/image/downing1.png) 收藏  |  浏览/下载:26/0  |  提交时间:2020/10/26 CONCURRENT CISPLATIN-RADIOTHERAPY ADJUVANT CHEMOTHERAPY RANDOMIZED-TRIAL STAGING SYSTEM CANCER CHEMORADIOTHERAPY METAANALYSIS CHINA SURVIVAL UNION Nasopharyngeal carcinoma Pathologic classification Prognosis |
| Active and passive smoking with breast cancer risk for Chinese females: a systematic review and meta-analysis 期刊论文 CHINESE JOURNAL OF CANCER, 2014, 卷号: 33 -
![](/themes/default/image/downing1.png) 收藏  |  浏览/下载:32/0  |  提交时间:2020/10/26 WOMEN POLYMORPHISMS ALCOHOL TAIWAN SUSCEPTIBILITY POPULATION PREVALENCE MORTALITY DISEASE TOBACCO Systematic review meta-analysis active smoking passive smoking breast cancer Chinese females |
| Novel anti-melanoma treatment: focus on immunotherapy 期刊论文 CHINESE JOURNAL OF CANCER, 2014, 卷号: 33 作者: Hao MengZe; Zhou WenYa; Du XiaoLing; Chen KeXin; Wang GuoWen; Yang Yun; Yang JiLong
![](/themes/default/image/downing1.png) 收藏  |  浏览/下载:49/0  |  提交时间:2020/12/28 HIGH-DOSE INTERLEUKIN-2 EMD 521873 SELECTIKINE PHASE-III TRIAL METASTATIC MELANOMA MEK INHIBITION CLINICAL-TRIAL BRAF IPILIMUMAB CANCER VACCINATION Melanoma immunotherapy tumor vaccine cytokine CTLA-4 PD-1 |